Skip to main content

Table 3 Factors associated with the mortality of ipCRC and spCRC

From: Second primary colorectal cancer in adults: a SEER analysis of incidence and outcomes

 

ipCRC

spCRC

Model 1

Model 2

Model 1

Model 2

HR

P

HR

P

HR

P

HR

P

Age

1.04 (1.04–1.04)

 < 0.001

1.04 (1.04–1.04)

 < 0.001

1.02 (1.01–1.02)

 < 0.001

1.02 (1.02–1.03)

 < 0.001

Gender

 Female

Ref

 

Ref

 

Ref

 

Ref

 

 Male

1.00 (0.99–1.01)

0.999

0.88 (0.87–0.89)

 < 0.001

1.05 (0.97–1.14)

0.236

1.13 (1.04–1.23)

0.003

Race

 White (ref)

Ref

 

Ref

 

Ref

 

Ref

 

 black

1.10 (1.09–1.12)

 < 0.001

1.15 (1.13–1.17)

 < 0.001

1.14 (1.01–1.29)

0.031

1.20 (1.06–1.35)

0.004

 Other

0.83 (0.81–0.84)

 < 0.001

0.86 (0.84–0.87)

 < 0.001

-

-

  

 Unknown

0.13 (0.11–0.15)

 < 0.001

0.18 (0.15–0.21)

 < 0.001

0.86 (0.74–0.99)

0.033

0.89 (0.77–1.02)

0.100

Insurance

 Insured

Ref

 

Ref

 

Ref

 

Ref

 

 Uninsured

1.56 (1.54–1.59)

 < 0.001

1.45 (1.42–1.47)

 < 0.001

1.02 (0.77–1.36)

 < 0.001

1.36 (1.16–1.59)

0.001

 Insured/No specifics

1.16 (1.14–1.17)

 < 0.001

1.13 (1.11–1.14)

 < 0.001

1.10 (0.96–1.27)

0.1726

0.76 (0.69–0.83)

 < 0.001

 Any Medicaid

1.30 (1.28–1.32)

 < 0.001

1.10 (1.08–1.12)

 < 0.001

1.35 (1.19–1.57)

0.001

1.09 (0.94–1.25)

0.250

 Unknown

1.28 (1.24–1.33)

 < 0.001

1.45 (1.40–1.51)

 < 0.001

0.73 (0.66–0.80)

0.730

1.22 (0.92–1.63)

0.167

Site

 Right colon

Ref

 

Ref

 

Ref

 

Ref

 

 Left colon

0.79 (0.78–0.80)

 < 0.001

0.94 (0.93–0.95)

 < 0.001

0.77 (0.67–0.89)

 < 0.001

0.87 (0.74–1.02)

0.081

 Others

2.81 (2.74–2.88)

 < 0.001

1.35 (1.31–1.38)

 < 0.001

0.89 (0.78–1.03)

0.113

1.12 (0.95–1.33)

0.184

 Rectum

0.78 (0.77–0.79)

 < 0.001

0.88 (0.86–0.89)

 < 0.001

0.93 (0.61–1.41)

0.734

1.61 (0.86–3.01)

0.134

Histology

 Adenocarcinoma

Ref

 

Ref

 

Ref

 

Ref

 

 Mucous adenocarcinoma

1.14 (1.12–1.16)

 < 0.001

1.06 (1.04–1.08)

 < 0.001

0.91 (0.79–1.06)

0.226

0.88 (0.75–1.02)

0.084

 Signet ring cell carcinoma

2.22 (2.13–2.32)

 < 0.001

1.40 (1.34–1.46)

 < 0.001

1.64 (1.20–2.24)

0.002

1.64 (1.19–2.25)

0.002

 Others

0.71 (0.70–0.72)

 < 0.001

0.85 (0.83–0.86)

 < 0.001

0.80 (0.72–0.88)

 < 0.001

0.93 (0.82–1.06)

0.259

Grade

 Grade I/Grade II

Ref

 

Ref

 

Ref

 

Ref

 

 Grade III/Grade IV

1.48 (1.45–1.51)

 < 0.001

1.15 (1.11–1.18)

 < 0.001

1.20 (1.08–1.33)

 < 0.001

0.99 (0.89–1.11)

0.947

 Unknown

2.01 (1.96–2.06)

 < 0.001

1.27 (1.22–1.30)

 < 0.001

0.95 (0.84–1.07)

0.367

1.05 (0.91–1.22)

0.507

T stage

 T1/T2

Ref

 

Ref

 

Ref

 

Ref

 

 T3

1.52 (1.50–1.55)

 < 0.001

1.17 (1.14–1.20)

 < 0.001

1.46 (1.33–1.61)

 < 0.001

1.12 (0.93–1.37)

0.224

 T4

3.25 (3.19–3.30)

 < 0.001

1.76 (1.71–1.80)

 < 0.001

2.23 (1.96–2.54)

 < 0.001

1.63 (1.32–2.01)

 < 0.001

 Unknown

0.69 (0.66–0.72)

 < 0.001

1.17 (1.14–1.20)

 < 0.001

1.25 (1.09–1.44)

0.001

1.19 (0.85–1.67)

0.030

N stage

 N0

Ref

 

Ref

 

Ref

 

Ref

 

 N1

1.52 (1.50–1.54)

 < 0.001

1.18 (1.15–1.21)

 < 0.001

1.45 (1.31–1.61)

 < 0.001

1.06 (0.85–1.32)

0.586

 N2

2.45 (2.42–2.49)

 < 0.001

1.80 (1.76–1.84)

 < 0.001

1.91 (1.70–2.15)

 < 0.001

1.36 (1.08–1.72)

0.010

 N3

-

-

-

-

1.85 (0.69–4.94)

0.219

-

-

 NX

1.81 (1.78–1.84)

 < 0.001

1.05 (1.02–1.08)

 < 0.001

1.07 (0.92–1.24)

0.382

1.86 (0.66–5.22)

0.241

M stage

 M0

Ref

 

Ref

 

Ref

 

Ref

 

 M1

5.54 (5.48–5.61)

 < 0.001

3.00 (2.61–3.45)

 < 0.001

2.44 (2.13–2.78)

 < 0.001

4.51 (2.00–10.18)

0.001

 MX

1.23 (1.21–1.26)

 < 0.001

0.76 (0.73–0.79)

 < 0.001

0.85 (0.73–0.99)

0.044

0.75 (0.52–1.08)

0.120

AJCC

 0

Ref

 

Ref

     

 I

1.20 (1.16–1.25)

 < 0.001

1.14 (1.10–1.19)

 < 0.001

Ref

-

Ref

 

 II

1.68 (1.62–1.75)

 < 0.001

1.24 (1.18–1.30)

 < 0.001

1.39 (1.24–1.55)

 < 0.001

1.15 (0.93–1.43)

0.188

 III

2.18 (2.09–2.27)

 < 0.001

1.55 (1.48–1.63)

 < 0.001

1.85 (1.65–2.07)

 < 0.001

1.47 (1.08–1.98)

0.013

 IV

9.31 (8.95–9.68)

 < 0.001

1.84 (1.59–2.13)

 < 0.001

3.08 (2.65–3.58)

 < 0.001

0.61 (0.27–1.36)

0.227

 Unknown stage

2.47 (2.37–2.57)

 < 0.001

1.84 (1.74–1.94)

 < 0.001

1.23 (1.06–1.43)

0.006

1.14 (0.79–1.63)

0.483

 Radiation (No/Unknown)

1.06 (1.05–1.08)

 < 0.001

1.04 (1.01–1.07)

 < 0.001

1.23 (1.10–1.38)

 < 0.001

1.82 (1.43–2.33)

 < 0.001

 Chemotherapy

0.85 (0.84–0.86)

 < 0.001

1.47 (1.45–1.49)

 < 0.001

1.29 (1.19–1.40)

 < 0.001

0.94 (0.84–1.04)

 < 0.001

Radiation sequence

 Only one

Ref

 

Ref

 

Ref

 

Ref

 

 After surgery

0.90 (0.88–0.93)

 < 0.001

1.39 (1.33–1.44)

 < 0.001

1.24 (1.06–1.46)

0.007

0.68 (0.47–0.81)

0.001

 Before surgery

0.60 (0.58–0.61)

 < 0.001

1.35 (1.31–1.40)

 < 0.001

0.95 (0.77–1.16)

0.597

0.55 (0.40–0.74)

 < 0.001

 Both

0.77 (0.56–1.08)

0.128

1.17 (0.84–1.64)

0.347

0.44 (0.11–1.76)

0.246

0.37 (0.09–1.49)

0.160

 Unknown

1.79 (1.55–2.05)

 < 0.001

1.39 (1.20–1.60)

 < 0.001

0.39 (0.06–2.78)

0.349

0.39 (0.05–2.80)

0.350

  1. spCRC second primary colorectal cancer, ipCRC initial primary colorectal cancer, AJCC American Joint Committee on Cancer, HR hazard ratio, CI confidence interval
  2. Model 1 Univariate cox regression analysis
  3. Model 2 Multivariable cox regression analysis including variables with statistical difference in Model 1